Gennova has also got permission for phase-2 and 3 clinical trials for its lyophilised mRNA vaccine for injection from the subject expert committee advising the Central Drugs Standards Control......
While there is a shortage of testing kits, manpower and capacities, India does not have other scalable testing options, report Vinay Umarji and Sohini Das. IMAGE: A medical worker collects the......
India's first mRNA platform-based vaccine will remain stable at 2-8 degrees Celsius while Pfizer-BioNTech's vaccine needs minus 70 degrees Celsius and Moderna vaccine can remain stable for six......